Who are Fentanyl and bupivacaine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Tramadol with ropivacaine.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/fentanyl-and-bupivacaine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Fentanyl and bupivacaine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fentanyl and bupivacaine (Fentanyl and bupivacaine) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Opioid analgesic combined with local anesthetic. Area: Anesthesia and Pain Management.

marketed Opioid analgesic combined with local anesthetic Mu opioid receptor (fentanyl); voltage-gated sodium channels (bupivacaine) Anesthesia and Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Fentanyl and bupivacaine (Fentanyl and bupivacaine) — Hospital Central Dr. Luis Ortega. Fentanyl is a potent opioid agonist that binds mu opioid receptors to provide analgesia, while bupivacaine is a local anesthetic that blocks sodium channels to prevent nerve signal transmission.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Fentanyl and bupivacaine TARGET	Fentanyl and bupivacaine	Hospital Central Dr. Luis Ortega	marketed	Opioid analgesic combined with local anesthetic	Mu opioid receptor (fentanyl); voltage-gated sodium channels (bupivacaine)
Tramadol with ropivacaine	Tramadol with ropivacaine	Aristotle University Of Thessaloniki	marketed	Opioid analgesic combined with local anesthetic	Mu-opioid receptor (tramadol); voltage-gated sodium channels (ropivacaine)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Opioid analgesic combined with local anesthetic class)

Aristotle University Of Thessaloniki · 1 drug in this class
Hospital Central Dr. Luis Ortega · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fentanyl and bupivacaine — Competitive Intelligence Brief. https://druglandscape.com/ci/fentanyl-and-bupivacaine. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab